Journal
CANCER RESEARCH
Volume 81, Issue 9, Pages 2358-2372Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-20-3510
Keywords
-
Categories
Funding
- National Institutes of Health [CA253095, AR056296, AI124346, AI101935]
- American Lebanese Syrian Associated Charities
Ask authors/readers for more resources
Macrophages play critical roles in tissue homeostasis, cell proliferation, and tumor metastasis. Tumor-associated macrophages (TAM) are known for their immunosuppressive functions in solid tumors, with MYD88 playing a key role in tumor progression. Targeting the MYD88/IL1 receptor axis could potentially enhance anti-tumor effects in a variety of cancers through regulating immune responses.
Macrophages are critical mediators of tissue homeostasis, cell proliferation, and tumor metastasis. Tumor-associated macrophages (TAM) are generally associated with tumor-promoting immunosuppressive functions in solid tumors. Here, we examined the transcriptional landscape of adaptor molecules downstream of Toll-like receptors in human cancers and found that higher expression of MYD88 correlated with tumor progression. In murine melanoma, MyD88, but not Trif, was essential for tumor progression, angiogenesis, and maintaining the immunosuppressive phenotype of TAMs. In addition, MyD88 expression in myeloid cells drove melanoma progression. The MyD88/IL1 receptor (IL1R) axis regulated programmed cell death (PD)-1 expression on TAMs by promoting recruitment of NF-kappa Bp65 to the Pdcd1 promoter. Furthermore, a combinatorial immunotherapy approach combining the MyD88 inhibitor with anti-PD-1 blockade elicited strong antitumor effects. Thus, the MyD88/IL1R axis maintains the immunosuppressive function of TAMs and promotes tumor growth by regulating PD-1 expression. Significance: These findings indicate that MyD88 regulates TAM-immunosuppressive activity, suggesting that macrophage-mediated immunotherapy combining MYD88 inhibitors with PD-1 blockade could result in better treatment outcomes in a wide variety of cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available